Annals of Neurology: Vol 63, No 3

I consent to Wiley Online Library’s Terms of Use and processing of my personal data as disclosed in Wiley’s Privacy Policy.I consent to my personal information being transferred outside of the People’s Republic of China as laid out in Wiley’s Privacy Policy.*(Optional) I consent to special offers, newsletter & promotions from Wiley. See Privacy Policy for more details.

Journal Metrics

Annals of Clinical and Translational Neurology presents interACTN: Interactive patient cases to refine your clinical skills.

Explore the impact of, and learn from, your decisions in our FREE neurology patient case series, interACTN.

Read the case history
Request tests on the patient
Arrive at the correct diagnosis

Test your knowledge now on any of our patient cases.

More from this journal

The American Neurological Association is a professional society of academic neurologists and neuroscientists devoted to advancing the goals of academic neurology; to training and educating neurologists and other physicians in the neurologic sciences; and to expanding both our understanding of diseases of the nervous system and our ability to treat them.

Learn More >>

Related Titles

The ANA-CNS family of top neurology and child neurology journals.

Follow ANA on social media

Annals of Neurology

Journal list menu

Tools

Follow journal

Annals of Neurology: Volume 63, Issue 3

Download PDFs

Message from the Editor

T2 clinical research: Judgment day

NerveCenter

NerveCenter: Translating stem cells to the clinic: The good, the bad, and the ugly

Discoveries in Neuroscience

Discoveries in Neuroscience

Editorials

A treatment for neurally mediated syncope? (Don't) hold your breath

Are adenosine antagonists, such as istradefylline, caffeine, and chocolate, useful in the treatment of Parkinson's disease?

Editorial

Is varicella zoster virus really involved in the pathogenesis of multiple sclerosis?

Neurological Progress

Repairing the human brain after stroke: I. Mechanisms of spontaneous recovery

Original Articles

Enhanced vascular responses to hypocapnia in neurally mediated syncope

Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces “off” time in Parkinson's disease: A double-blind, randomized, multicenter clinical trial (6002-US-005)

Varicella-zoster virus in cerebrospinal fluid at relapses of multiple sclerosis

Identification of neuronal outgrowth cells from peripheral blood of stroke patients

Dysferlin-deficient muscular dystrophy features amyloidosis

Mutations in TPM3 are a common cause of congenital fiber type disproportion

Adenosine A2A receptor antagonists exert motor and neuroprotective effects by distinct cellular mechanisms

Risk factors for sporadic Creutzfeldt–Jakob disease

Saccadic palsy after cardiac surgery: characteristics and pathogenesis

Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: significance of dicysteine C30C31 motif

A new amyloid β variant favoring oligomerization in Alzheimer's-type dementia

Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson's disease

Brief Communications

Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial†

Mitochondrial complex I deficiency caused by a deleterious NDUFA11 mutation

Letters

Transient epileptic amnesia: Old syndrome or new?

Reply

Brief Communications

Lesion distribution in children with clinically isolated syndromes

Sign up for email alerts

More from this journal

Adenosine A_2A receptor antagonist istradefylline (KW-6002) reduces “off” time in Parkinson's disease: A double-blind, randomized, multicenter clinical trial (6002-US-005)

Adenosine A_2A receptor antagonists exert motor and neuroprotective effects by distinct cellular mechanisms

Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial ^†